Duck
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Anseriformes; Anatidae,
Latin Name:
Anas platyrhynchos domesticus
Tested tissues: Lung,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0050 | 2021.04 | 10X Genomics | Lung | Normal | 19818 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Severe acute respiratory syndrome coronavirus 2 | |
|
Human betaherpesvirus 5 |
Lung-Secretory cells : 95.30% ; Lung-ATI : 90.10% ; Lung-ATII : 87.17% ; Lung-Ciliated cells : 83.50% ; Lung-Fibroblasts : 75.62% ; Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; |
|
Hepacivirus C |
Lung-Secretory cells : 95.30% ; Lung-ATI : 90.10% ; Lung-ATII : 87.17% ; Lung-Ciliated cells : 83.50% ; Lung-Fibroblasts : 75.62% ; Lung-Ciliated cells : 53.18% ; Lung-Endothelial cells : 51.86% ; Lung-Secretory cells : 51.17% ; Lung-Fibroblasts : 45.38% ; Lung-B cells : 41.78% ; Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; Lung-ATI : 7.13% ; Lung-Ciliated cells : 6.97% ; Lung-B cells : 6.85% ; Lung-Macrophages : 6.12% ; Lung-Secretory cells : 6.01% ; Lung-T cells : 5.26% ; Lung-Secretory cells : 2.87% ; Lung-Ciliated cells : 2.05% ; |
|
Influenza A virus |
Lung-Secretory cells : 95.30% ; Lung-ATI : 90.10% ; Lung-ATII : 87.17% ; Lung-Ciliated cells : 83.50% ; Lung-Fibroblasts : 75.62% ; Lung-Fibroblasts : 93.58% ; Lung-Ciliated cells : 68.14% ; Lung-Endothelial cells : 67.83% ; Lung-Macrophages : 67.35% ; Lung-Secretory cells : 66.84% ; Lung-Ciliated cells : 69.57% ; Lung-Secretory cells : 58.22% ; Lung-Macrophages : 51.02% ; Lung-ATII : 48.01% ; Lung-ATI : 41.17% ; Lung-T cells : 36.84% ; Lung-ATI : 34.92% ; Lung-Secretory cells : 31.07% ; Lung-Macrophages : 30.61% ; Lung-Endothelial cells : 30.15% ; |
|
Varicella Zoster Virus |
Lung-Ciliated cells : 76.02% ; Lung-Secretory cells : 68.41% ; Lung-Endothelial cells : 58.01% ; Lung-B cells : 57.53% ; Lung-Fibroblasts : 57.43% ; |
|
Human alphaherpesvirus 3 |
Lung-Ciliated cells : 76.02% ; Lung-Secretory cells : 68.41% ; Lung-Endothelial cells : 58.01% ; Lung-B cells : 57.53% ; Lung-Fibroblasts : 57.43% ; |
|
Vesicular stomatitis virus |
Lung-Ciliated cells : 69.57% ; Lung-Secretory cells : 58.22% ; Lung-Macrophages : 51.02% ; Lung-ATII : 48.01% ; Lung-ATI : 41.17% ; |
|
Nipah henipavirus |
Lung-Endothelial cells : 59.30% ; Lung-Secretory cells : 46.48% ; Lung-B cells : 42.47% ; Lung-Ciliated cells : 41.80% ; Lung-ATII : 37.94% ; |
|
Hendra henipavirus |
Lung-Endothelial cells : 59.30% ; Lung-Secretory cells : 46.48% ; Lung-B cells : 42.47% ; Lung-Ciliated cells : 41.80% ; Lung-ATII : 37.94% ; |
|
Simian rotavirus A strain RRV |
Lung-Ciliated cells : 54.20% ; Lung-Secretory cells : 51.70% ; Lung-Macrophages : 51.02% ; Lung-B cells : 49.32% ; Lung-ATII : 48.54% ; Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; Lung-Fibroblasts : 16.45% ; Lung-Endothelial cells : 8.58% ; Lung-Secretory cells : 8.36% ; Lung-Macrophages : 8.16% ; Lung-Ciliated cells : 6.56% ; |
|
Foot-and-mouth disease virus |
Lung-Secretory cells : 52.74% ; Lung-ATII : 21.43% ; Lung-Ciliated cells : 18.44% ; Lung-ATI : 8.39% ; Lung-Endothelial cells : 6.39% ; Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; Lung-Ciliated cells : 36.07% ; Lung-Secretory cells : 18.80% ; Lung-ATI : 14.96% ; Lung-T cells : 10.53% ; Lung-ATII : 9.12% ; Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; |
|
Coxsackievirus B1 | |
|
Coxsackievirus A9 | |
|
Human alphaherpesvirus 1 |
Lung-Secretory cells : 52.74% ; Lung-ATII : 21.43% ; Lung-Ciliated cells : 18.44% ; Lung-ATI : 8.39% ; Lung-Endothelial cells : 6.39% ; Lung-Ciliated cells : 36.07% ; Lung-Secretory cells : 18.80% ; Lung-ATI : 14.96% ; Lung-T cells : 10.53% ; Lung-ATII : 9.12% ; Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; Lung-Secretory cells : 16.19% ; Lung-Endothelial cells : 12.42% ; Lung-T cells : 10.53% ; Lung-Macrophages : 10.20% ; Lung-Ciliated cells : 9.94% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Latino mammarenavirus |
Lung-ATI : 47.11% ; Lung-ATII : 39.58% ; Lung-Ciliated cells : 37.30% ; Lung-Secretory cells : 34.99% ; Lung-Fibroblasts : 33.36% ; |
|
Oliveros mammarenavirus |
Lung-ATI : 47.11% ; Lung-ATII : 39.58% ; Lung-Ciliated cells : 37.30% ; Lung-Secretory cells : 34.99% ; Lung-Fibroblasts : 33.36% ; |
|
Lassa mammarenavirus |
Lung-ATI : 47.11% ; Lung-ATII : 39.58% ; Lung-Ciliated cells : 37.30% ; Lung-Secretory cells : 34.99% ; Lung-Fibroblasts : 33.36% ; Lung-T cells : 42.11% ; Lung-Secretory cells : 38.12% ; Lung-Ciliated cells : 33.91% ; Lung-Endothelial cells : 29.97% ; Lung-Macrophages : 28.57% ; Lung-ATI : 8.95% ; Lung-Secretory cells : 8.62% ; Lung-Endothelial cells : 7.70% ; Lung-Ciliated cells : 6.66% ; Lung-ATII : 5.45% ; |
|
Canine coronavirus |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Feline coronavirus |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Infectious bronchitis virus |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Human coronavirus 229E |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Porcine epidemic diarrhea virus |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Transmissible gastroenteritis virus |
Lung-Endothelial cells : 45.49% ; Lung-Ciliated cells : 37.81% ; Lung-ATII : 37.71% ; Lung-B cells : 37.67% ; Lung-Secretory cells : 37.34% ; |
|
Mammalian orthoreovirus | |
|
Echovirus E8 | |
|
Human parvovirus B19 |
Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; |
|
Human gammaherpesvirus 4 |
Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; |
|
Human metapneumovirus |
Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; |
|
Human rotavirus strain WA | |
|
Echovirus E1 | |
|
Equid alphaherpesvirus 1 | |
|
Adeno-associated virus - 2 |
Lung-Endothelial cells : 45.37% ; Lung-T cells : 42.11% ; Lung-Fibroblasts : 40.83% ; Lung-ATII : 37.58% ; Lung-ATI : 37.37% ; Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; Lung-Secretory cells : 25.59% ; Lung-ATI : 12.27% ; Lung-ATII : 12.24% ; Lung-Fibroblasts : 11.87% ; Lung-Endothelial cells : 11.64% ; |
|
Sin Nombre orthohantavirus |
Lung-Endothelial cells : 45.12% ; Lung-Macrophages : 28.57% ; Lung-Fibroblasts : 27.98% ; Lung-ATII : 27.01% ; Lung-Secretory cells : 26.37% ; |
|
Andes orthohantavirus |
Lung-Endothelial cells : 45.12% ; Lung-Macrophages : 28.57% ; Lung-Fibroblasts : 27.98% ; Lung-ATII : 27.01% ; Lung-Secretory cells : 26.37% ; |
|
Bovine leukemia virus |
Lung-Secretory cells : 44.13% ; Lung-Endothelial cells : 35.01% ; Lung-Ciliated cells : 34.53% ; Lung-ATII : 34.07% ; Lung-Fibroblasts : 31.15% ; |
|
Xenotropic murine leukemia virus |
Lung-Ciliated cells : 37.30% ; Lung-Secretory cells : 28.98% ; Lung-Endothelial cells : 28.16% ; Lung-Fibroblasts : 26.31% ; Lung-B cells : 22.60% ; |
|
Polytropic murine leukemia virus |
Lung-Ciliated cells : 37.30% ; Lung-Secretory cells : 28.98% ; Lung-Endothelial cells : 28.16% ; Lung-Fibroblasts : 26.31% ; Lung-B cells : 22.60% ; |
|
Rabies lyssavirus |
Lung-Fibroblasts : 36.83% ; Lung-Ciliated cells : 28.48% ; Lung-Endothelial cells : 18.21% ; Lung-Secretory cells : 16.97% ; Lung-B cells : 11.64% ; |
|
Human papillomavirus type 16 | |
|
Dengue virus |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; Lung-ATI : 8.95% ; Lung-Secretory cells : 8.62% ; Lung-Endothelial cells : 7.70% ; Lung-Ciliated cells : 6.66% ; Lung-ATII : 5.45% ; Lung-T cells : 5.26% ; Lung-Secretory cells : 2.87% ; Lung-Ciliated cells : 2.05% ; |
|
Adeno-associated virus 9 |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
Classical swine fever virus |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
Adeno-associated virus - 3 |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
Sindbis virus |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
Adeno-associated virus - 8 |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
Venezuelan equine encephalitis virus |
Lung-Ciliated cells : 29.30% ; Lung-Macrophages : 28.57% ; Lung-Secretory cells : 28.46% ; Lung-T cells : 26.32% ; Lung-B cells : 26.03% ; |
|
West Nile virus |
Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; |
|
Human parechovirus 1 |
Lung-Secretory cells : 27.15% ; Lung-T cells : 26.32% ; Lung-Endothelial cells : 23.29% ; Lung-Ciliated cells : 23.26% ; Lung-ATI : 20.67% ; |
|
Human mastadenovirus C | |
|
Human gammaherpesvirus 8 | |
|
Human alphaherpesvirus 2 |
Lung-Secretory cells : 16.19% ; Lung-Endothelial cells : 12.42% ; Lung-T cells : 10.53% ; Lung-Macrophages : 10.20% ; Lung-Ciliated cells : 9.94% ; |
|
Bovine alphaherpesvirus 1 |
Lung-Secretory cells : 16.19% ; Lung-Endothelial cells : 12.42% ; Lung-T cells : 10.53% ; Lung-Macrophages : 10.20% ; Lung-Ciliated cells : 9.94% ; |
|
Suid alphaherpesvirus 1 |
Lung-Secretory cells : 16.19% ; Lung-Endothelial cells : 12.42% ; Lung-T cells : 10.53% ; Lung-Macrophages : 10.20% ; Lung-Ciliated cells : 9.94% ; |
|
Feline leukemia virus strain B/lambda-B1 |
Lung-T cells : 15.79% ; Lung-Ciliated cells : 14.96% ; Lung-Secretory cells : 12.53% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 8.12% ; |
|
Gibbon ape leukemia virus |
Lung-T cells : 15.79% ; Lung-Ciliated cells : 14.96% ; Lung-Secretory cells : 12.53% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 8.12% ; |
|
Amphotropic murine leukemia virus |
Lung-T cells : 15.79% ; Lung-Ciliated cells : 14.96% ; Lung-Secretory cells : 12.53% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 8.12% ; |
|
Coxsackievirus A10 |
Lung-Fibroblasts : 14.64% ; Lung-Secretory cells : 11.49% ; Lung-Ciliated cells : 10.55% ; Lung-Endothelial cells : 9.78% ; Lung-B cells : 6.85% ; |
|
Ecotropic murine leukemia virus |
Lung-Ciliated cells : 14.55% ; Lung-T cells : 5.26% ; Lung-Secretory cells : 2.35% ; |
|
Feline panleukopenia virus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Guanarito mammarenavirus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Canine parvovirus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Machupo mammarenavirus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Argentinian mammarenavirus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Mouse mammary tumor virus |
Lung-Macrophages : 14.29% ; Lung-T cells : 10.53% ; Lung-Endothelial cells : 6.60% ; Lung-ATII : 6.53% ; Lung-Secretory cells : 6.53% ; |
|
Onyong-nyong virus |
Lung-Fibroblasts : 13.48% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 7.52% ; Lung-Secretory cells : 6.53% ; Lung-T cells : 5.26% ; |
|
Chikungunya virus | |
|
Ross River virus |
Lung-Fibroblasts : 13.48% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 7.52% ; Lung-Secretory cells : 6.53% ; Lung-T cells : 5.26% ; |
|
Mayaro virus |
Lung-Fibroblasts : 13.48% ; Lung-Macrophages : 8.16% ; Lung-Endothelial cells : 7.52% ; Lung-Secretory cells : 6.53% ; Lung-T cells : 5.26% ; |
|
Feline leukemia virus strain C/FA27 |
Lung-ATII : 12.37% ; Lung-Secretory cells : 9.14% ; Lung-Ciliated cells : 6.76% ; Lung-Endothelial cells : 5.82% ; Lung-ATI : 4.91% ; |
|
Coxsackievirus A16 |
Lung-Macrophages : 12.24% ; Lung-Secretory cells : 5.48% ; Lung-B cells : 5.48% ; Lung-ATI : 5.30% ; Lung-Endothelial cells : 4.49% ; |
|
Enterovirus A71 |
Lung-Macrophages : 12.24% ; Lung-Secretory cells : 5.48% ; Lung-B cells : 5.48% ; Lung-ATI : 5.30% ; Lung-Endothelial cells : 4.49% ; |
|
Ebola virus | |
|
Zika virus |
Lung-ATI : 8.95% ; Lung-Secretory cells : 8.62% ; Lung-Endothelial cells : 7.70% ; Lung-Ciliated cells : 6.66% ; Lung-ATII : 5.45% ; |
|
Marburg marburgvirus |
Lung-ATI : 8.95% ; Lung-Secretory cells : 8.62% ; Lung-Endothelial cells : 7.70% ; Lung-Ciliated cells : 6.66% ; Lung-ATII : 5.45% ; |
|
JC polyomavirus |
Lung-Fibroblasts : 8.51% ; Lung-T cells : 5.26% ; Lung-Endothelial cells : 3.94% ; Lung-Secretory cells : 3.39% ; Lung-Ciliated cells : 2.77% ; |
|
Porcine reproductive and respiratory syndrome virus |
Lung-Secretory cells : 4.70% ; Lung-Ciliated cells : 4.61% ; Lung-Endothelial cells : 4.14% ; Lung-ATII : 4.10% ; Lung-Macrophages : 4.08% ; |